Our Leadership
ACS NPCRT Leadership
The ACS NPCRT uses a triad leadership model consisting of an external Chair, an external Vice Chair, and an ACS Chair. These “Tri-Chairs,” in collaboration with ACS staff, lead and support the Steering Committee. In this model, the ACS serves as the backbone organization which provides organizational leadership, resources, and expert staff to support the Roundtable in the execution of its Strategic Plan.
ACS NPCRT Steering Committee
The Steering Committee provides leadership and vision to help advance the ACS NPCRT mission. The Committee proactively develops, refines, and implements the Strategic Plan, as well as monitors the Roundtable’s performance and progress toward the Plan’s execution.

Brian Bragg, M.S.
Zero Prostate Cancer
Chief Mission Officer

Peter L Choyke, MD
National Cancer Institute
Senior Investigator

Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education
Prostate Health Education Network

Ruth Etzioni, PhD
Fred Hutch Cancer Center
Professor

Lannis Hall, MD, MPH
Director of Radiation Oncology
Associate Professor of Clinical Radiation Oncology Siteman Cancer Center, Washington University School of Medicine

Ingrid J. Hall, PhD, MPH
Division of Cancer Prevention and Control, CDC
Epidemiologist

Elisabeth Heath, MD, FACP
Department of Oncology, Mayo Clinic
Chair

Lorelei Mucci, ScD, MPH
Professor of Epidemiology, Head of Cancer Epidemiology and Prevention
Harvard T.H. Chan School of Public Health
Senior Scientific Advisor

Walter Rayford, MD, PhD, MBA
Consortium on Disparities of Urologic Conditions
Executive Director

Brian Rivers, PhD, MPH, BS
Morehouse School of Medicine
Director, Professor

Phillip E. Rodgers, MD, FAAHPM
Professor of Family Medicine and Internal Medicine
University of Michigan Medical School

Howard Soule, PhD
Prostate Cancer Foundation
Chief Science Officer